Structural insights into the binding modes of lanreotide and pasireotide with somatostatin receptor 1. [PDF]
Zeng Z +11 more
europepmc +1 more source
Targeted β<sup>-</sup>-Particle Plus Conversion and Auger-Electron Therapy with <sup>161</sup>Tb-Labeled Somatostatin Receptor Antagonist DOTA-LM3: A Phase 0 Study. [PDF]
Fricke JG +14 more
europepmc +1 more source
Clinical Experience with Targeted Alpha-Emitter Peptide Receptor Radionuclide Therapy (α-PRRT) for Somatostatin Receptor-Positive Neuroendocrine Tumors. [PDF]
Leupe H +5 more
europepmc +1 more source
Evaluating the diagnostic accuracy of <sup>99m</sup>Tc-labeled somatostatin receptor imaging for suspected pheochromocytomas and paragangliomas. [PDF]
Li B +6 more
europepmc +1 more source
Somatostatin receptor scintigraphy in sarcoidosis
Kamphuis Lieke SJ +5 more
doaj +1 more source
Somatostatin Receptor Scintigraphy in Autoimmune Syndrome Induced by Silicone Breast Implants: Pre- and Postexplantation Findings. [PDF]
Anzola LK +5 more
europepmc +1 more source
Prediction of lesion-based response to PRRT using baseline somatostatin receptor PET. [PDF]
Aouf A +7 more
europepmc +1 more source
In Vivo Versus In Vitro Somatostatin Receptor Expression in Neuroendocrine Neoplasms: A Systematic Review and Meta-Analysis of Correlation Studies. [PDF]
Perrone E +5 more
europepmc +1 more source
Peptide Receptor Radionuclide Therapy with Lu-177-DOTATATE and Monitoring with Somatostatin Receptor PET/CT in Patients with Advanced Differentiated Thyroid Carcinoma. [PDF]
Kunte SC +11 more
europepmc +1 more source

